Turning Point Therapeutics' GAAP loss for 6M 2021 was $91.777 million, down 0.5% from $92.211 million in the prior year. Revenue was $30.369 million. The company did not generate revenue a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept